The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash Regulatory News (KP2)

Share Price Information for Kore Potash (KP2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.50
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.05 (10.00%)
Open: 0.525
High: 0.525
Low: 0.525
Prev. Close: 0.525
KP2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ASX waiver in relation to quotation of CDIs

10 Apr 2018 08:00

RNS Number : 3898K
Kore Potash PLC
10 April 2018
 

10 April 2018

 

Kore Potash Plc

("Kore Potash" or the "Company")

ASX waiver in relation to quotation of CDIs and lodgement of Appendix 3Bs

 

Kore Potash is pleased to announce a decision by ASX in response to the Company's application for a waiver of ASX Listing Rule 2.4 and ASX Listing Rule 2.8.

These waivers relate to the ASX quotation of CDIs on issue, as distinct from the total number of ordinary shares on issue, and the lodgement of Appendix 3Bs relating to the net change in the number of CDIs issued in the Australian market.

The decision by ASX reads as follows:

"1. Based solely on the information provided, and in connection with the listing of Kore Potash PLC (the "Company") on the Alternative Investment Market of the London Stock Exchange, ASX Limited ("ASX") grants the Company:

1.1. A waiver from listing rule 2.4 to the extent necessary to permit the Company to only apply for quotation of those CHESS Depositary Interests ("CDIs") issued over its fully paid ordinary shares into the Australian market.

1.2. A waiver from listing rule 2.8 to the extent necessary to allow the Company not to apply for quotation of CDIs which are issued as a result of holders of ordinary shares in the Company converting their shares to CDIs within 10 business days of issue of those CDIs.

2. The waivers in Resolution 1 are granted subject to the following conditions.

2.1. The Company applies for quotation of CDIs issued into the Australian market on a monthly basis, and the Company provides to the market a monthly update of the net changes in the number of CDIs that are quoted on ASX.

2.2. The Company immediately releases full details of these waivers to the market."

The grant of these waivers will reduce the administrative burden on the Company while ensuring that the market is updated regularly about the number of CDIs in existence.

 

ENDS

For further information, please visit www.korepotash.com or contact:

Kore Potash

Sean Bennett - CEO

 

 

Tel: +27 11 469 9140

 

Tavistock Communications

Jos Simson

Edward Lee

 

 

Tel: +44 (0) 20 7920 3150

 

Canaccord Genuity - Nomad and Broker

Martin Davison

James Asensio

 

 

Tel: +44 (0) 20 7523 4600

 

Fivemark Partners

Michael Vaughan

 

Tel: +61 422 602 720

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUPACUPRUQU
Date   Source Headline
5th Dec 20187:00 amRNSCDI Monthly Movement
21st Nov 20187:00 amRNSExtensions to Sylvinite Deposits Expected
16th Nov 201811:06 amRNSSecond Price Monitoring Extn
16th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSCDI Monthly Movement
1st Nov 20187:00 amRNSDefinitive Feasibility Study ("DFS") Received
30th Oct 20189:01 amRNSCashflow Report for Q3 2018
30th Oct 20189:00 amRNSReview of Operations for Q3 2018
5th Oct 20189:00 amRNSCDI Monthly Movement
1st Oct 20187:00 amRNSCompany Secretary Change
28th Sep 20187:15 amRNSDefinitive Feasibility Study Update
12th Sep 201810:15 amRNSFINANCIAL REPORT FOR HALF YEAR ENDED 30 JUNE 2018
12th Sep 20187:00 amRNSDedicated Offshore Transhipment Area Licenced
10th Sep 20189:00 amRNSCDI Monthly Movement
28th Aug 20188:30 amRNSApproval of ESIA for Dougou licence area
20th Aug 201810:00 amRNSMaiden Sylvinite MRE at Dougou Extension
7th Aug 20183:23 pmRNSDirector/PDMR Shareholding - Replacement
7th Aug 20189:32 amRNSCDI Monthly Movement
7th Aug 20189:31 amRNSDirector / PDMR Shareholdings
7th Aug 20189:30 amRNSDirector / PDMR Shareholding
2nd Aug 20187:02 amRNSDirector Interest Notice
2nd Aug 20187:01 amRNSAppendix 3B
2nd Aug 20187:00 amRNSDirector Interest Notices
31st Jul 20187:01 amRNSReview of Operations for Q2 2018
31st Jul 20187:00 amRNSCashflow Report for Q2 2018
18th Jul 20189:30 amRNSCDI Monthly Movement
27th Jun 201811:01 amRNSResults of AGM
27th Jun 201811:00 amRNSExpiry of unlisted options
12th Jun 20188:45 amRNSCDI Monthly Movement
1st Jun 20188:00 amRNSAnnual Financial Report
30th May 20187:00 amRNSAppointment of CEO
23rd May 20187:00 amRNSAppointment of a Non-Executive Director
4th May 20188:00 amRNSCDI Monthly Movement
30th Apr 20189:31 amRNSReview of Operations for Q1 2018
30th Apr 20189:30 amRNSCashflow Report for Q1 2018
26th Apr 20183:40 pmRNSAdmission Document Disclosures
26th Apr 20183:37 pmRNSHolding(s) in Company
26th Apr 20181:30 pmRNSDirector Resignation
18th Apr 201810:00 amRNSExpiry of Unlisted Options
17th Apr 20189:30 amRNSDirector/PDMR Shareholding
13th Apr 20189:00 amRNSDirector/PDMR Shareholding
10th Apr 20188:00 amRNSASX waiver in relation to quotation of CDIs
9th Apr 201810:20 amRNSDirector/PDMR Shareholding
5th Apr 20181:09 pmRNSDirector/PDMR Shareholding
4th Apr 20181:55 pmRNSNotice under Section 708A
4th Apr 20181:49 pmRNSAppendix 3B
3rd Apr 20187:00 amRNSAnnual Financial Report
29th Mar 20187:00 amRNSAdmission to AIM and JSE and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.